Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA)-Reference-Cited by-同舟云学术

Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA)

Published:2014-09-27 Issue:16 Volume:74 Page:1674-1690
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Tykvart J.¹²,Navrátil V.¹²,Sedlák F.¹³,Corey E.⁴,Colombatti M.⁵,Fracasso G.⁵,Koukolík F.⁶,Bařinka C.⁷,Šácha P.¹²,Konvalinka J.¹²

Affiliation:

1. Gilead Sciences and IOCB Research Centre; Institute of Organic Chemistry and Biochemistry; Academy of Sciences of the Czech Republic; Czech Republic

2. Department of Biochemistry; Faculty of Natural Science; Charles University; Czech Republic

3. First Faculty of Medicine; Charles University in Prague; Czech Republic

4. Genitourinary Cancer Research Laboratory; Department of Urology; University of Washington; Seattle

5. Department of Pathology and Diagnostics; Section of Immunology; University of Verona; Verona Italy

6. Department of Pathology and Molecular Medicine; Thomayer Teaching Hospital; Czech Republic

7. Institute of Biotechnology; Academy of Sciences of the Czech Republic; Czech Republic

Funder

Czech Science Foundation

Publisher

Wiley

Subject

Urology,Oncology

Reference69 articles.

1. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer;Ghosh;J Cell Biochem,2004

2. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium;Liu;Cancer Res,1997

3. Prostate-specific membrane antigen expression in normal and malignant human tissues;Silver;Clin Cancer Res,1997

4. GCPII imaging and cancer;Foss;Curr Med Chem,2012

5. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer;Mesters;EMBO J,2006

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GCP III is not the “off-target” for urea-based PSMA ligands;European Journal of Nuclear Medicine and Molecular Imaging;2023-05-16

2. Molecular Design of ⁶⁸Ga- and ⁸⁹Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors;Molecular Pharmaceutics;2023-04-17

3. Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target;Molecular & Cellular Oncology;2022-10-24

4. Advances in Prostate‐Specific Membrane Antigen (PSMA)‐Targeted Phototheranostics of Prostate Cancer;Small Structures;2022-05-10

5. Comparison of low-molecular-weight ligand and whole antibody in prostate-specific membrane antigen targeted near-infrared photoimmunotherapy;International Journal of Pharmaceutics;2021-11